Ribosomal RNA methylation in HSCs: it's so “good for you”
suggesting that robust and sustained CAR T-cell expansion is necessary for durable clinical benefit.Fourth, efficacy was observed across high-risk subgroups, including all 3 patients with extramedullary disease, who achieved sCR.
Authors
- Konstantinos Tzelepis (ORCID: https://orcid.org/0000-0002-4865-7648)
- Judith López (ORCID: https://orcid.org/0000-0003-3202-9935)
Institutions
- University of Cambridge (GB)
- Wellcome Sanger Institute (GB)
Publication Details
- Journal
- Blood
- Published
- 2026-01-29
- DOI
- https://doi.org/10.1182/blood.2025032073
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00